Research
Sell
A Sell rating means lf0 research identifies a meaningful gap between a companys current valuation and its underlying fundamentals, typically driven by decelerating growth, margin pressure, balance-sheet risk, or a competitive position eroding faster than the market has priced in. Sell-rated companies carry a risk/reward skew that favors caution over the timeframe of the analysis.




The Scorecard: 1 Month Update: GTN Sell — Correct so far
Revisiting our Sell call on GTN: entry $4.83, latest $4.44, -8.1%.
The Scorecard: 1 Month Update: RRGB Sell — Correct so far
Revisiting our Sell call on RRGB: entry $9.51, latest $7.05, -25.9%.
The Scorecard: 1 Month Update: PENN Sell — Correct so far
Revisiting our Sell call on PENN: entry $18.56, latest $16.45, -11.4%.
The Scorecard: 3 Month Update: BW Sell — Correct so far
Revisiting our Sell call on BW: entry $17.76, latest $7.36, -58.6%.
Planet Labs Stock Analysis: Buy or Sell? Valuation, Margin & Leverage
Planet Labs PBC (PL) is a SELL as rapid revenue growth has not yet justified its 15.4x EV/revenue multiple. Net debt/EBITDA of 7.6x and ongoing…
ASE Technology Stock Analysis: Buy or Sell? Valuation, FCF & Growth
ASE Technology Holding Co., Ltd. (ASX) is rated Sell as strong revenue growth has not yet translated into free cash flow. The stock screens expensive…
The Scorecard: 2 Month Update: MARA Sell — Correct so far
Revisiting our Sell call on MARA: entry $11.67, latest $11.64, -0.3%.
The Scorecard: 3 Month Update: AEHR Sell — Correct so far
Revisiting our Sell call on AEHR: entry $115.30, latest $90.55, -21.5%.
The Scorecard: 1 Month Update: SDGR Sell — Incorrect so far
Revisiting our Sell call on SDGR: entry $17.40, latest $23.93, +37.5%.
The Scorecard: 2 Month Update: MYRG Sell — Correct so far
Revisiting our Sell call on MYRG: entry $391.51, latest $275.37, -29.7%.
Most Popular Research